Literature DB >> 28748150

Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.

Rahman Shah1,2, Glenda Delgado1, Shannon W Finks3.   

Abstract

Entities:  

Year:  2017        PMID： 28748150      PMCID： PMC5509930          DOI： 10.21037/cdt.2016.11.07

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  8 in total

1.  Randomized trials or observational tribulations?

Authors:  S J Pocock; D R Elbourne
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

Authors:  Katrin A Fiedler; Michael Maeng; Julinda Mehilli; Stefanie Schulz-Schüpke; Robert A Byrne; Dirk Sibbing; Petra Hoppmann; Simon Schneider; Massimiliano Fusaro; Ilka Ott; Steen D Kristensen; Tareq Ibrahim; Steffen Massberg; Heribert Schunkert; Karl-Ludwig Laugwitz; Adnan Kastrati; Nikolaus Sarafoff
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

Review 3.  Triple antithrombotic management after stent implantation: when and how?

Authors:  Albert Schömig; Nikolaus Sarafoff; Melchior Seyfarth
Journal:  Heart       Date:  2009-08       Impact factor: 5.994

4.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).

Authors:  Gregory Y H Lip; Stephan Windecker; Kurt Huber; Paulus Kirchhof; Francisco Marin; Jurriën M Ten Berg; Karl Georg Haeusler; Giuseppe Boriani; Davide Capodanno; Martine Gilard; Uwe Zeymer; Deirdre Lane; Robert F Storey; Hector Bueno; Jean-Philippe Collet; Laurent Fauchier; Sigrun Halvorsen; Maddalena Lettino; Joao Morais; Christian Mueller; Tatjana S Potpara; Lars Hvilsted Rasmussen; Andrea Rubboli; Juan Tamargo; Marco Valgimigli; Jose L Zamorano
Journal:  Eur Heart J       Date:  2014-08-25       Impact factor: 29.983

5.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2016-03-29       Impact factor: 24.094

6.  Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Konstantinos C Koskinas; Lorenz Räber; Thomas Zanchin; Thomas Pilgrim; Stefan Stortecky; Lukas Hunziker; Stefan Blöchlinger; Michael Billinger; Fabienne Gartwyl; Christina Moro; Aris Moschovitis; Peter Jüni; Dik Heg; Stephan Windecker
Journal:  JACC Cardiovasc Interv       Date:  2016-07-25       Impact factor: 11.195

7.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

Review 8.  Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.

Authors:  Chirag Bavishi; Anna Koulova; Sripal Bangalore; Ashwin Sawant; Saurav Chatterjee; Sameer Ather; Jose Valencia; Nikolaus Sarafoff; Andrea Rubboli; Juhani K Airaksinen; Gregory Y H Lip; Jacqueline E Tamis-Holland
Journal:  Catheter Cardiovasc Interv       Date:  2015-09-10       Impact factor: 2.692
  8 in total
  1 in total

1.  Triple antithrombotic therapy in patients undergoing percutaneous coronary intervention: balancing between ischemia and bleeding.

Authors:  Konstantinos C Koskinas; Lorenz Räber
Journal:  Cardiovasc Diagn Ther       Date:  2017-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.